U.S. Supreme Court,
Torts/Personal Injury,
9th U.S. Circuit Court of Appeals
Dec. 13, 2021
US high court to decide on review of $25M weedkiller verdict
While a ruling in Bayer’s favor on the preemption issue would be significant, it would not be a “silver bullet” against all current and future claims since other types of claims could be and have been asserted.
Bayer AG could reverse the tide in the national Monsanto Roundup litigation if the U.S. Supreme Court grants review this week of a $25 million bellwether jury verdict awarded to a California man who said the weed killer caused his non-Hodgkin's lymphoma.
Pharmaceutical giant Bayer, Monsanto's parent company, filed its petition for a writ of certiorari with the U.S. Supreme Court in August, hoping to limit liability in more than 100,000 law...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
U.S. Supreme Court, Torts/Personal Injury, Alternative Dispute Resolution
‘Encouraged’ Bayer suspends weedkiller settlement talks
By Blaise Scemama
Evidence
Hardeman v. Monsanto
District court did not abuse its discretion in admitting International Agency for Research on Cancer's classification of glyphosate as 'probably carcinogenic.'
